Previous Close | 4,360.00 |
Open | 4,361.00 |
Bid | 4,335.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 4,302.00 - 4,365.00 |
52 Week Range | 2,724.00 - 4,396.00 |
Volume | |
Avg. Volume | 18,375 |
Market Cap | 40B |
Beta (5Y Monthly) | 0.46 |
PE Ratio (TTM) | 44.84 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 68.00 (1.57%) |
Ex-Dividend Date | Mar 25, 2024 |
1y Target Est | N/A |
BLANQUEFORT, France & VERNIER, Switzerland, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 - Ticker: ALKEM), today announced the signature of a definitive agreement with Givaudan, world leader in the creation of flavors and fragrances (ISIN code: CH0010645932 - Ticker: GIVN), concerning the acquisition of Naturex Iberian Partners (Givaudan's industrial site in Valencia - Spain).